ImmuPharma (LON:IMM) Trading 4.9% Higher – Here’s Why

by · The Markets Daily

ImmuPharma plc (LON:IMM – Get Free Report)’s stock price was up 4.9% during trading on Saturday . The stock traded as high as GBX 4.70 ($0.06) and last traded at GBX 3.67 ($0.04). Approximately 109,382,164 shares changed hands during mid-day trading, an increase of 245% from the average daily volume of 31,664,631 shares. The stock had previously closed at GBX 3.50 ($0.04).

ImmuPharma Price Performance

The company has a market capitalization of £15.30 million, a price-to-earnings ratio of -367.30 and a beta of 1.53. The stock has a 50 day simple moving average of GBX 1.40 and a two-hundred day simple moving average of GBX 1.65.

ImmuPharma Company Profile

(Get Free Report)

ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease.

Featured Articles